Ursprung des Netzwerks ersten Grades von Lindi Tan
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lindi Tan
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Nanyang Technological University | College/University | Undergraduate Degree | |
| Zhejiang University | College/University | Undergraduate Degree | |
Themes Investment Management Ltd.
 Themes Investment Management Ltd. Investment ManagersFinance Themes Investment Management Ltd is a private equity firm founded in 2009. The firm is headquartered in Hong Kong. | Investment Managers | Corporate Officer/Principal | |
| FAR EAST HORIZON LIMITED | Finance/Rental/Leasing | Corporate Officer/Principal | |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Medical Specialties | Director/Board Member Director/Board Member | |
| HUGEL, INC. | Biotechnology | Director/Board Member | |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group (Singapore) Pte. Ltd.(CBC Group) is a private equity firm founded in 2014 by Wei Fu. The firm is headquartered in Singapore with additional offices in New York, Hong Kong, Shanghai and Beijing and is wholly owned by CBC Group Investment Management Ltd. | Investment Managers | Chief Executive Officer | |
| EVEREST MEDICINES LIMITED | Pharmaceuticals: Major | Chairman | |
| CBC Group Co., Ltd. | Chief Executive Officer | ||
AffaMed Therapeutics
 AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology AffaMed Therapeutics is a Chinese company focused on providing innovative treatments to patients. The company is based in Shanghai, CN. The company's mission and vision are centered around improving patient access to these treatments. The company has a pipeline of products in development to achieve this goal. and has subsidiaries in United States and Hong Kong. The CEO of the company is Dayao Zhao. | Pharmaceuticals: Major | Chairman | |
| I-MAB | Pharmaceuticals: Major | Director/Board Member | |
| C-Bridge Capital Investment Management Ltd. | Chief Executive Officer | ||
| Standard Chartered Business Consulting Beijing Co. Ltd. | Corporate Officer/Principal | ||
Everest Medicines II Ltd.
 Everest Medicines II Ltd. Pharmaceuticals: MajorHealth Technology Everest Medicines II Ltd. develops and commercializes pharmaceutical products. The private company is based in Road Town, Cayman Islands. | Pharmaceuticals: Major | Director/Board Member | |
| Everest Medicines II HK Ltd. | Director/Board Member | ||
| Everest Medicines (Singapore) Pte Ltd. | Director/Board Member | ||
| Everonc Medicines Ltd. | Director/Board Member | ||
| Everonc Medicines, Inc. | Director/Board Member | ||
| Everest Medicines II BVI Ltd. | Director/Board Member | ||
Affamed Therapeutics (Us), Inc.
 Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Part of AffaMed Therapeutics, Affamed Therapeutics (US), Inc. is a clinical stage biopharmaceutical company based in New York, NY. The company focuses on developing and commercializing pharmaceutical, digital, and surgical products to address critical unmet medical needs in ophthalmological, neurological, and psychiatric disorders for patients worldwide. The CEO of the company is Dayao Zhao. | Pharmaceuticals: Major | Director/Board Member | |
| Ascletis BioScience Co., Ltd. | Director/Board Member | ||
| Gannex LLC | Corporate Officer/Principal | ||
| Ascletis Pharmaceuticals Co., Ltd. | Corporate Officer/Principal | ||
C-Bridge Capital GP IV Ltd.
 C-Bridge Capital GP IV Ltd. Financial ConglomeratesFinance Part of CBC Group Investment Management Ltd., C-Bridge Capital GP IV Ltd. provides investment services. | Financial Conglomerates | Director/Board Member |
Statistik
International
| China | 8 |
| Vereinigte Staaten | 6 |
| Singapur | 4 |
| Hong Kong | 4 |
| Cayman Islands | 4 |
Sektoral
| Health Technology | 8 |
| Finance | 5 |
| Consumer Services | 3 |
Operativ
| Director/Board Member | 15 |
| Corporate Officer/Principal | 6 |
| Chief Executive Officer | 3 |
| Chairman | 2 |
| Undergraduate Degree | 2 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Wei Fu | 21 |
| Judy Hejingdao Wu | 6 |
| Zhengqing Li | 1 |
| Jianjiong Wang | 1 |
